McCormick & Co -V
MKC.V
46.72
-0.09
-0.19%
McCormick & Co -V
US · MKC.V
#1289 by market cap
Listed 1970
46.72
-0.09
-0.19%
Live - 5344 symbols - heartbeat 73s ago
· 2026-10-07 19:54
After-hours
46.72
0.00%
- Market cap
- 12.57B
- P/E (TTM)i
- 8.45
- P/Bi
- 1.79
- EPSi
- 2.93
- Div yieldi
- 4.05%
- 52W posi
- 10%
Reader sentiment
Are you bullish or bearish on MKC.V?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.13, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +1.73% YoY
Margins
- Gross margin
- 37.90%
- Operating margin
- 15.96%
- Net margin
- 11.54%
Key ratios & quality
- Enterprise valuei
- 16.47B
- PEG ratioi
- 1.69
- Altman Z-Scorei
- 2.13
PEG uses trailing P/E against the 3-year net income growth rate (5.00%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.30B | 5.35B | 5.60B | 6.32B | 6.35B | 6.66B | 6.72B | 6.84B |
| Gross profit | 2.09B | 2.15B | 2.30B | 2.49B | 2.27B | 2.50B | 2.59B | 2.59B |
| Selling & admin expenses | 1.16B | 1.17B | 1.28B | 1.40B | 1.36B | 1.48B | 1.52B | 1.50B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 929.90M | 978.50M | 1.02B | 1.09B | 917.40M | 1.02B | 1.07B | 1.09B |
| Pretax profit | 741.30M | 819.20M | 881.50M | 895.80M | 812.80M | 798.70M | 898.30M | 913.00M |
| Tax | -157.30M | 157.40M | 174.90M | 192.70M | 168.60M | 174.50M | 184.00M | 195.80M |
| Net profit | 933.40M | 702.70M | 747.40M | 755.30M | 682.00M | 680.60M | 788.50M | 789.40M |
| Basic EPS | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Diluted EPS | 3.50 | 2.62 | 2.78 | 2.80 | 2.52 | 2.52 | 2.92 | 2.93 |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Revenue | 1.66B | 1.72B | 1.85B | 1.87B | 1.94B | 2.02B |
| Gross profit | 622.80M | 645.10M | 720.30M | 708.90M | 778.20M | 794.90M |
| Selling & admin expenses | 364.20M | 352.50M | 404.80M | 456.30M | 441.80M | 436.40M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 258.60M | 292.60M | 315.50M | 252.60M | 336.40M | 358.50M |
| Pretax profit | 204.60M | 247.90M | 274.00M | 185.00M | 220.20M | 154.50M |
| Tax | 49.30M | 39.30M | 65.60M | 48.70M | 63.50M | 49.90M |
| Net profit | 176.00M | 227.70M | 222.30M | 1.02B | 160.20M | 107.60M |
| Basic EPS | 1 | 1 | 1 | 4 | 1 | 0 |
| Diluted EPS | 0.65 | 0.84 | 0.84 | 3.77 | 0.56 | 0.36 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.48B | 1.55B | 2.08B | 2.20B | 2.39B | 2.00B | 2.14B | 2.14B |
| Cash & ST investments | 96.60M | 155.40M | 423.60M | 351.70M | 334.00M | 166.60M | 186.10M | 95.90M |
| Inventory | 786.30M | 801.20M | 1.03B | 1.18B | 1.34B | 1.13B | 1.24B | 1.27B |
| Total assets | 10.26B | 10.36B | 12.09B | 12.91B | 13.12B | 12.86B | 13.07B | 13.20B |
| Total current liabilities | 2.00B | 2.15B | 3.05B | 3.22B | 3.43B | 3.10B | 2.88B | 3.06B |
| Short-term debt | 643.50M | 698.40M | 1.15B | 1.31B | 1.51B | 1.07B | 748.30M | 890.50M |
| Long-term debt | 4.05B | 3.63B | 3.75B | 3.97B | 3.64B | 3.34B | 3.59B | 3.11B |
| Total liabilities | 7,074,200,000.00 | 6,905,400,000.00 | 8,149,700,000.00 | 8,480,300,000.00 | 8,425,700,000.00 | 7,778,800,000.00 | 7,753,500,000.00 | 7,432,300,000.00 |
| Total equity | 3.18B | 3.46B | 3.94B | 4.43B | 4.70B | 5.08B | 5.32B | 5.77B |
| Retained earnings | 1.76B | 2.06B | 2.42B | 2.78B | 3.02B | 3.25B | 3.55B | 3.82B |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Total current assets | 2.17B | 2.22B | 2.14B | 2.61B | 2.79B | 2.90B |
| Cash & ST investments | 124.10M | 94.90M | 95.90M | 177.70M | 331.20M | 331.10M |
| Inventory | 1.31B | 1.32B | 1.27B | 1.37B | 1.41B | 1.45B |
| Total assets | 13.19B | 13.25B | 13.20B | 16.35B | 16.48B | 16.65B |
| Total current liabilities | 3.19B | 3.12B | 3.06B | 3.44B | 3.57B | 4.42B |
| Short-term debt | 1.36B | 1.25B | 890.50M | 1.32B | 1.34B | 2.11B |
| Long-term debt | 3.10B | 3.10B | 3.11B | 3.60B | 3.60B | 2.91B |
| Total liabilities | 7,560,000,000.00 | 7,463,400,000.00 | 7,432,300,000.00 | 8,790,200,000.00 | 8,903,800,000.00 | 9,063,500,000.00 |
| Total equity | 5.63B | 5.78B | 5.77B | 7.56B | 7.57B | 7.59B |
| Retained earnings | 3.74B | 3.84B | 3.82B | 4.82B | 4.84B | 4.81B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 821.20M | 946.80M | 1.04B | 828.30M | 651.50M | 1.24B | 921.90M | 962.20M |
| Depreciation & amortization | 150.70M | 158.80M | 165.00M | 186.30M | 200.60M | 199.30M | 208.80M | 231.30M |
| Free cash flow | 652.10M | 773.10M | 816.00M | 550.30M | 389.50M | 973.40M | 647.00M | 740.40M |
| Dividends paid | -273.40M | -302.20M | -330.10M | -363.30M | -396.70M | -418.50M | -451.00M | -483.00M |
| Stock buybacks / issuance | -62.30M | -95.10M | -47.30M | -8.60M | -38.80M | -35.70M | -53.10M | -34.80M |
| Ending cash balance | 96.60M | 155.40M | 423.60M | 351.70M | 334.00M | 166.60M | 186.10M | 95.90M |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Operating cash flow | 45.90M | 258.80M | 542.00M | 50.90M | 379.80M | 168.10M |
| Depreciation & amortization | 57.10M | 61.20M | 59.20M | 63.00M | 73.50M | 76.60M |
| Free cash flow | -2.40M | 206.10M | 458.30M | 18.40M | 337.10M | 112.10M |
| Dividends paid | -120.80M | -120.70M | -120.80M | -128.90M | -129.00M | -149.90M |
| Stock buybacks / issuance | -9.30M | -2.70M | -5.60M | -10.90M | -8.40M | 8.40M |
| Ending cash balance | 124.10M | 94.90M | 95.90M | 177.70M | 331.20M | 331.10M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 32.57 | 21.25 | 20.28 | 18.12 | 15.00 | 13.97 | 15.23 | 14.32 |
| ROA %i | 9.04 | 6.82 | 6.66 | 6.04 | 5.24 | 5.24 | 6.08 | 6.01 |
| ROIC %i | 13.73 | 10.70 | 10.18 | 9.13 | 7.94 | 8.29 | 9.44 | 9.26 |
| 5-year avg ROE %i | 26.15 | 25.70 | 25.11 | 23.01 | 21.44 | 17.72 | 16.52 | 15.33 |
| EBIT margin %i | 16.93 | 18.41 | 18.16 | 16.34 | 15.15 | 15.11 | 16.47 | 16.22 |
| FCF / sales %i | 12.06 | 14.46 | 14.57 | 8.71 | 6.13 | 14.61 | 9.62 | 10.82 |
| Current ratioi | 0.74 | 0.72 | 0.68 | 0.68 | 0.70 | 0.65 | 0.74 | 0.70 |
| Quick ratioi | 0.31 | 0.31 | 0.31 | 0.28 | 0.26 | 0.24 | 0.27 | 0.24 |
| Debt / assetsi | 45.79 | 41.73 | 41.42 | 41.75 | 40.58 | 35.70 | 34.49 | 31.54 |
| LT debt / equityi | 127.82 | 105.27 | 98.25 | 92.48 | 81.58 | 69.55 | 71.07 | 57.06 |
| Interest coveragei | 5.25 | 5.96 | 7.50 | 7.56 | 6.45 | 4.84 | 5.29 | 5.65 |
| Revenue CAGR (3Y) %i | 7.27 | 6.62 | 5.80 | 6.01 | 5.90 | 5.95 | 2.10 | 2.51 |
| Net income CAGR (3Y) %i | 32.46 | 14.16 | 16.12 | -6.81 | -0.99 | -3.07 | 1.44 | 5.00 |
| FCF CAGR (3Y) %i | 12.21 | 15.31 | 8.84 | -5.50 | -20.43 | 6.06 | 5.54 | 23.88 |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| ROE %i | 14.19 | 13.92 | 14.32 | 26.58 | 25.70 | 23.37 |
| ROA %i | 5.93 | 5.88 | 6.01 | 11.27 | 10.91 | 9.97 |
| ROIC %i | 9.43 | 9.31 | 9.26 | 16.64 | 16.16 | 14.82 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 16.42 | 16.29 | 16.22 | 15.57 | 15.35 | 13.52 |
| FCF / sales %i | 8.18 | 9.65 | 10.82 | 9.57 | 13.81 | 12.05 |
| Current ratioi | 0.68 | 0.71 | 0.70 | 0.76 | 0.78 | 0.66 |
| Quick ratioi | 0.22 | 0.24 | 0.24 | 0.29 | 0.29 | 0.26 |
| Debt / assetsi | 33.77 | 32.90 | 31.54 | 30.12 | 29.94 | 30.14 |
| LT debt / equityi | 55.33 | 53.97 | 57.06 | 51.63 | 51.42 | 41.50 |
| Interest coveragei | 5.38 | 5.46 | 5.65 | 5.67 | 5.49 | 5.05 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Consumer is the largest reported line at 60.03% of revenue, across 2 reported segments.
- Flavor Solutions follows at 39.97%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Consumer60.03%
Flavor Solutions39.97%
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.